Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New pacer states:

Actually I believe it is you who makes the mistake. The 148 patent is all about the on-chip memory and the amount of it. There is no infringement of the 148 unless more than half of available surface is allocated to memory. That percentage of on-chip memory is the critical piece of the 148.

Opty

Share
New Message
Please login to post a reply